Exagen Inc (XGN) — Cash Flow Reinvestment Rate
Latest as of June 2026:
0.14x
Exagen Inc (XGN) has a Cash Flow Reinvestment Rate of 0.14x as of June 2026, reinvesting $543.00K (capex $543.00K ) from operating cash flow of $3.99 Million. See XGN FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.14x
(Capex + Investments) / Operating CF
Total Reinvested
$543.00K
Capex + Investments
Operating Cash Flow
$3.99 Million
USD
Capital Expenditures
$543.00K
USD
Annual Cash Flow Reinvestment Rate for Exagen Inc (None–None)
Year-by-year capital reinvestment analysis for Exagen Inc. See financial flexibility index of Exagen Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow